VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
Clinical trial NCT02718443 · COMPLETED
Trial details
- NCT number
- NCT02718443
- Sponsor
- Vaximm GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-08-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.